Co-Diagnostics Overview
Co-Diagnostics (CODX) has a P/E ratio of -0.04, below the Healthcare sector average of 25.3.
Get informed when a big investor buys or sells
+ Follow-0.04
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for CODX is -0.04. That is below the Healthcare sector average of 25.3. Investors often review this figure alongside Co-Diagnostics's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, CODX currently prints -0.04 for P/E ratio, while the sector average sits near 25.3. That is roughly 100.2% below the sector mean. Large gaps often invite a closer look at Co-Diagnostics's growth, margins, and balance sheet.
A P/E ratio of -0.04 for Co-Diagnostics is not 'good' or 'bad' on its own. Compare it with the peer average (25.3) and with CODX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting CODX's P/E ratio (-0.04), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Co-Diagnostics's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
